Zyprexa

Transitioning Patients to Olanzapine LAI

Zyprexa (olanzapine), a well-established atypical antipsychotic, provides prescribers with a highly effective and well-tolerated option for managing schizophrenia and bipolar I disorder (manic or mixed episodes). Its robust clinical profile, demonstrated across numerous studies, underscores its efficacy in achieving symptomatic relief and maintaining clinical improvement in appropriate patient populations. CHEPLAPHARM is committed to ensuring the continued availability of Zyprexa, supporting clinicians in delivering optimal patient care.

More About Zyprexa